S2 Episode 5: Is It Time to Screen for Multiple Myeloma?

S2 Episode 5: Is It Time to Screen for Multip...

Recommended Episodes

Episode 044: Myeloma Series, Pt.5 - Myeloma Treatment
The Fellow on Call: The Heme/Onc Podcast

In this continuation of our myeloma series, we build on our prior discussion about myeloma pharmacology, this time discussing how to select the optimal regimen for treatment of our patients.

Co ...

  Show more

Episode 048: Myeloma Series, Pt.9- Transplant in Myeloma Capstone
The Fellow on Call: The Heme/Onc Podcast

In episode 046, we discussed the fundamentals of transplant in the treatment of patients with multiple myeloma. This week, we sit down with two incredible hematologists who specialize in transplant to discuss the real-life decision-making ...

  Show more

Thinking Beyond TROP2 at ESMO 2023
Medscape InDiscussion: Triple-Negative Breast Cancer

What were the biggest takeaways from ESMO 2023 related to TNBC and IBC? Tune in to hear experts Drs Kevin Kalinsky and Filipa Lynce discuss. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991259). The topics and dis ...  Show more

Episode 042: Myeloma Series, Pt.3 - Intro to Multiple Myeloma
The Fellow on Call: The Heme/Onc Podcast

In this continuation of our myeloma series, we discuss the progression of MGUS & smoldering myeloma to multiple myeloma. We also outline how to risk stratify a patient with multiple myeloma and gauge their response to treatment.  ...

  Show more

Immunotherapy in TNBC: What's New, What's Next?
Medscape InDiscussion: Triple-Negative Breast Cancer

Join experts Drs Kevin Kalinsky and Heather McArthur as they discuss the latest studies guiding their decisions when treating patients with TNBC in clinic. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/991253). The ...  Show more